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Abstract
In virtually every cell, neutral lipids are stored in cytoplasmic structures called lipid droplets (LDs) and also referred to as lipid
bodies or lipid particles. We developed a rapid high-throughput assay based on the recovery of quenched BODIPY-
fluorescence that allows to quantify lipid droplets. The method was validated by monitoring lipid droplet turnover during
growth of a yeast culture and by screening a group of strains deleted in genes known to be involved in lipid metabolism. In
both tests, the fluorimetric assay showed high sensitivity and good agreement with previously reported data using
microscopy. We used this method for high-throughput identification of protein phosphatases involved in lipid droplet
metabolism. From 65 yeast knockout strains encoding protein phosphatases and its regulatory subunits, 13 strains revealed
to have abnormal levels of lipid droplets, 10 of them having high lipid droplet content. Strains deleted for type I protein
phosphatases and related regulators (ppz2, gac1, bni4), type 2A phosphatase and its related regulator (pph21 and sap185),
type 2C protein phosphatases (ptc1, ptc4, ptc7) and dual phosphatases (pps1, msg5) were catalogued as high-lipid droplet
content strains. Only reg1, a targeting subunit of the type 1 phosphatase Glc7p, and members of the nutrient-sensitive TOR
pathway (sit4 and the regulatory subunit sap190) were catalogued as low-lipid droplet content strains, which were studied
further. We show that Snf1, the homologue of the mammalian AMP-activated kinase, is constitutively phosphorylated
(hyperactive) in sit4 and sap190 strains leading to a reduction of acetyl-CoA carboxylase activity. In conclusion, our fast and
highly sensitive method permitted us to catalogue protein phosphatases involved in the regulation of LD metabolism and
present evidence indicating that the TOR pathway and the SNF1/AMPK pathway are connected through the Sit4p-Sap190p
pair in the control of lipid droplet biogenesis.
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Introduction
In virtually every cell, neutral lipids are stored in cytoplasmic
structures called lipid droplets (LDs) (rev. [1]). In the budding yeast
S. cerevisiae, these structures contain a neutral lipid core composed
of triacylglycerols (TAGs) and sterol esters (SEs) in a 1:1 ratio [2].
This core is delimited by a phospholipid monolayer associated
with a diversity of proteins, which have structural functions and
also show enzymatic activity [3,4]. LDs are thought to originate in
the endoplasmic reticulum [5,6]. It is thought that as TAG and SE
are synthesized, they accumulate between the internal and
external endoplasmic reticulum membrane leaflets until LDs bud
from the endoplasmic reticulum [7]. This hypothesis is reinforced
by the fact that the enzymes that contribute to the esterification of
fatty acids (FAs) and sterols (STEs) e.g., diacylglycerol acyltrans-
ferases Dga1p [8] and Lro1p [9], and acyl-CoA:sterol acyltrans-
ferases, Are1p and Are2p are localized to the endoplasmic
reticulum [10]. Among these enzymes, only Dga1p is found in
LDs [11]. Regarding the utilization of stored lipids, five enzymes
responsible for the mobilization of stored lipids are localized to the
LD. Three of these enzymes are TAG lipases – Tgl3p, Tgl4p and
Tgl5p [12,13] – and two are SE hydrolases – Yeh1p and Tgl1p
[14]. Remarkably, the major enzyme contributing to SE hydrolase
activity (Yeh2p) is localized at the plasma membrane [15]. This
raises the question of whether the LD is more than a mere neutral
lipid deposit. In fact, equilibrium between mobilization and LD
synthesis seems to be important in various aspects of metabolism,
such as cell cycle progression, that requires lipolysis [16],
membrane trafficking and ‘‘lipid buffering’’ to regulate levels of
free FA [17]. Once synthesized, free FAs and free STEs would
represent a lipotoxic threat [18] if not converted by esterification
into more biologically inert lipids, such as TAG and SEs, and then
stored in LDs. In yeast, deletion of the acyltransferases that esterify
fatty acids into TAGs and SEs lead to high sensitivity to
unsaturated fatty acids [19]. In mammals, LDs control the
synthesis and secretion of inflammatory mediators [20] and are
implicated in virus propagation [21]. Different stimuli and
signaling pathways are involved in the biogenesis of LDs; for
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13692example, in macrophages, leptin-induced LD formation is
mediated by phosphatidylinositol 3-kinase (PI3-K) and the
mammalian target of rapamycin (mTOR) pathways [22].
In yeast, LDs are quite dynamic organelles. It was observed that
they are consumed as a response to a proliferative stimulus, such as
the addition of rich medium to stationary cells. During the lag
phase of growth [23], when nutrients are abundant, lipid
mobilization provides construction blocks for the synthesis of
more complex lipids such as phospholipids. When cells enter the
exponential phase of growth, LDs are re-synthesized [23].
Nevertheless, little is known about the regulators and pathways
driving these dynamics. It is known that Snf1, a homolog to
mammalian AMP-activated kinase (AMPK), is a negative
regulator of fatty acid synthesis and, once phosphorylated,
mediates acetyl-CoA carboxylase phosphorylation and subsequent
inhibition [24,25]. In order to determine the role of protein
phosphorylation in the regulation of LD dynamics, we screened
yeast mutant strains in which protein phosphatases (including
catalytic and regulatory subunits) had been knocked out (no
phosphatase has been reported to regulate lipid droplet metabo-
lism). Since the techniques used in the study of lipids are laborious
and require time-consuming microscopic analysis, our group
developed a new fluorimetric method suitable for high-throughput
experiments. Nile red is an excellent fluorescent probe for
detection of intracellular lipid droplets by fluorescence microscopy
and flow cytofluorometry [26–28]. BODIPYH (4,4-difluoro-3a,4a,-
diaza-s-indacene) has also been used in LD microscopic studies,
and has previously been used for a screening of a yeast deletion
mutant collection for LD abnormalities [29]. Although both
molecules preferentially stain LDs, the latter seems to be more
specific [26]. Based on BODIPY fluorescence, we were able to
rapidly evaluate LD content without lipid extraction or micros-
copy analysis. Our results showed that this method is suitable for
following LD dynamics during yeast culture growth and can be
employed to screen a large number of mutants.
Using our new approach, we were able to identify 13 (out of 65)
phosphatase knockout strains that presented abnormal LD levels.
Among these, we further studied Sit4, a Ser/Thr protein
phosphatase, as a positive regulator of LD metabolism. We
propose that Sit4p, in association with its regulatory subunit
Sap190p, regulates lipid metabolism by controlling the phosphor-
ylation status of Snf1 kinase. In fact, the snf1-null strain showed
increased LD levels, confirming unpublished data from Kohlwein
and coworkers [30], while sit4- or sap190-null strains exhibited the
opposite phenotype, which is consistent with the hyperpho-
sphorylation of Snf1p observed in these strains.
Materials and Methods
Reagents
BODIPYH 493/503 (referred to here as BODIPY) was
purchased from Invitrogen, prepared as a 10 mM stock solution
in DMSO and kept at 270uC. Soraphen A was a gift from Rolf
Mu ¨ller (Helmoltz-Zentrum fu ¨r Infektionsforschung) and kept as a
0.1 mg/ml stock solution in 10% methanol. All other reagents
were from Sigma-Aldrich (St. Louis, MO).
Strains
Saccharomyces cerevisiae strain BY4741 (MATa his3D1 leu2D0
met15D0 ura3D0) and BY4741- MATa gene deletion library (Open
Biosystems). BY4742 (MATa his3D1 leu2D0 lys2D0 ura3D0),
dga1lro1 (MATa his3D1 leu2D0 lys2D0 ura3D0 dga1::KanMX
lro1::KanMX) and are1are2 (MATa his3D1 leu2D0 lys2D0 ura3D0
are1::KanMX are2::KanMX) were kindly provided by Sepp D.
Kohlwein (University of Graz, Austria).
Yeast growth and cell fixation
Saccharomyces cerevisiae strains were grown in YPD liquid-rich
medium (1% yeast extract, 2% peptone and 2% glucose) at 30uC.
For determination of LD content, aliquots were withdrawn during
growth and cells were immediately fixed by adding 1/9 volume of
formaldehyde (final concentration 3.7% v/v). After incubation for
15 min at 25uC, cells were collected by centrifugation (3000 rpm,
5 min) and washed once with distilled water. Cells were
resuspended in water and adjusted to 5 O.D.600 nm/ml and kept
at 4uC until use. For use in high-throughput screening selected
strains from the BY4741- MATa gene deletion library (Open
Biosystems) were cultured overnight in YPD medium in 96-well
plates. Afterwards they were transferred to fresh YPD medium
with the aid of a 96 -Pin Replicator and grown at 30uC with
shaking. Growth was monitored during 48 hours to ensure that all
deleted strains, even those that have a slow-growth phenotype, had
attained the stationary phase. The OD600 varied between 2.8–6.3.
The mean growth was OD600=4.260.6. Each sample was then
fixed by the addition of 22 ml of formaldehyde, incubated for
15 min at 25uC and washed with distilled water. Fixed cells were
harvested and resuspended in 200 ml of distilled water.
Liquid fluorescence recovery assay
LD content was determined by recovering the fluorescence of
quenched BODIPY following the addition of fixed cells (Figure 1).
For this purpose, 5 ml of a formaldehyde-fixed cell suspension was
added to 200 ml of quenched reading buffer containing 5 mM
BODIPY and 500 mM KI, all contained in a 96-well black-wall/
clear-bottom plate (Costar). The settings for fluorescence were
excitation 480 nm, emission 510 nm, cutoff filter at 495 nm, PMT
automatic. Concomitant to each fluorescence reading, the
quantity of cells was determined by measuring the absorbance at
600 nm. Each sample was read four times by adding subsequent 5-
ml aliquots of a formaldehyde-fixed cell suspension to the same
well. Reading blanks were acquired by incubating the reading
buffer for 5 min at 30uC before the addition of cells. Data quality
Figure 1. A schematic representation of the fluorescence
recovery assay. Based on the high specificity of the fluorescent
probe BODIPY 493/503 for lipid droplets, we designed a rapid
fluorimetric method for the evaluation of lipid droplets inside yeast
cells. With this method, BODIPY’s fluorescence is quenched in solution
and, when cells are added, fluorescence is recovered due to passive
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compared to cell number. From this curve, the relative
fluorescence per number of cells was determined and denoted
the lipid droplet index (LD index). If R-square ,0.9, data were
discarded (Figure S1 and Figure S2).
Statistical analysis of high-throughput experiments
In order to classify strains as high lipid droplet content (hlc)o r
low lipid droplet content (llc) with respect to wild-type, LD indexes
were compared as follows. For each independent experiment, the
LD index of each individual strain was normalized to the mean
LD index of all samples contained in the same plate. Then, the
mean LD index from four independent experiments was
compared to the mean LD index of the wild-type (WT) strain
(n=14). The F-test was performed to determine whether the
variability in the data collected for each deletion strain was similar
to that observed for the wild-type strain; a homoscedastic or
heteroscedastic t-test was employed accordingly. Strains with
values statistically different (p,0.05) were catalogued as hlc or llc
strains when the normalized LD index was at least 20% higher or
lower than that of the wild-type strain, respectively.
Quantification of lipid droplets by fluorescence
microscopy
Aliquots of 5 ml of cellular suspension (10 OD 600 nm) and
5 mlo f1 0mM BODIPY were mounted onto a polylysine-treated
glass slide. Microscopy was performed on Axio Observer.Z1
(Zeiss) or Olympus IX 81 using a 100x oil immersion objective.
Images captured were analyzed using ImageJ software and total
fluorescence was determined with the aid of the nucleus counter
and cell counter function of the Wright Cell Imaging Facility
(WCIF) plug-in collection. LDs were quantified in at least
50 cells.
Protein homogenate preparation and western blot
Total protein homogenates were prepared using the rapid
procedure described by Yaffe and Schatz [31] with minor
modifications. Briefly, 0.25 M NaOH and 1% b-mercaptoethanol
(final concentration) were added to culture samples, which were
then incubated at room temperature for 10 min, followed by the
addition of trichloroacetic acid to a final concentration of 6%.
Protein was collected by centrifugation and the pellets were stored
at 280uC until use. For western blot analysis, pellets were
resuspended directly in electrophoresis Laemlli sample buffer to
provide a 10-OD suspension. Aliquots of 10 ml of these extracts,
containing 0.1-OD cells, were separated in 7.5% SDS-acrylamide
gel using the Mini-Protean II (BioRad) and electrotransferred to
Immobilon-P for 30 min at 18 V in 25 mM Tris, 192 mM glycine
and 10% methanol, using a trans-blot semi-dry cell (BioRad).
Membranes were treated with anti-phospho-AMPKa Thr172
(Cell Signaling) or anti-Snf1p (Santa Cruz) antibodies. Blots were
detected using the chemiluminescence ECL Plus kit (GE
Healthcare).
Measurement of triacylglycerol
Cultures were grown in YPD medium, harvested by
centrifugation at 3000 rpm for 5 minutes at room temperature
and washed with distilled water. An aliquot of 15 OD cells was
resuspended in 300 ml of extraction buffer (50 mM Tris-HCl,
0.3% Triton X-100, pH 7.5) and lysed with glass beads vortexing
for 5 cycles of 30 seconds at 4uC. Lysed cells were separated and
the glass beads were washed with 300 ml of extraction buffer.
The total lysate was centrifuged at 3,000 rpm for ten minutes.
Neutral lipids were extracted from 200 ml of the supernatant as
described by Bligh & Dyer [32]. Briefly cells were incubated with
shaking for 5 minutes after successive addition of 750 ml
chloroform/methanol (1:2), 250 ml chloroform and 250 ml
distilled water. Tubes were centrifuged at 1,000 rpm for 5
minutes and the organic phase was dried under N2 vapor at
room temperature. Neutral lipids were resuspended in 150 mlo f
extraction buffer. Triglycerides were measured with a clinical kit
(Doles, Brazil) as indicated by the manufacturer. This kit is based
on hydrolysis of triacylglycerol with lipase and further determi-
nation of glycerol.
Soraphen A susceptibility tests
Drug susceptibilities were measured by both broth microdilu-
tion and spot assays. MICs for the strains were determined using
the broth microdilution method. Spot assays were carried out as in
[33]. Briefly, yeast strains were grown in YPD to stationary phase




YPD plus 2% agar with increasing concentrations of soraphen A
and then incubated for two days at 30uC, as previously described
[34]. For microdilution tests, cells from stationary culture were
diluted to 10
5 cells/ml in fresh YPD with increasing concentra-
tions of soraphen A in a total volume of 200 ml and then incubated
in 96-well microtiter plates at 30uC. Growth was recorded after
24 h by measuring absorbance at 600 nm. The IC50 was defined
as the drug concentration that inhibited growth by 50% compared
to growth of the drug-free controls.
Results
Liquid fluorescence recovery assay (LFR assay)
LDs are often visualized by microscopy after staining with Nile
red, osmium or BODIPY [35–37]. BODIPY has a lipophilic
nature and exhibits high specificity for lipid droplets [26]; these
qualities render the compound a good candidate to use as a
probe for LDs in a fluorescent liquid high-throughput experi-
ment. Based on fluorescence-quenched assays [38], we selected a
hydrophilic quencher that would permit BODIPY to fluoresce
only when localized inside LDs and not when present in solution
(Figure 1). Three classical fluorescence quenchers (KI, acrylam-
ide and tryptophan) were titrated against a 5 mMB O D I P Y
solution. The emission spectra (485 nm excitation) showed that
only KI quenched the fluorescence efficiently (Figure 2A–C).
From Stern-Volmer plots, where the quenching efficiency is
related to the total quencher concentration [39] it can be
observed that quenching increased linearly with increasing
concentrations of KI and tryptophane (Figure 2D,E) but not
acrylamide (Figure 2F). From these plots, a Stern-Volmer
constant of 44 and 14.1 was calculated for KI and acrylamide,
respectively. KI was selected as the quencher because a higher
F0/F ratio was reached with this compound as compared to
tryptophan in the conditions tested.
When fixed-formaldehyde cells were added to a BODIPY-KI-
quenched solution, fluorescence was recovered (Figure 3A). The
best linearity between the number of cells and recovered
fluorescence was obtained using KI in the quenching medium at
a concentration ranging from 0.25 M to 1.0 M. For subsequent
experiments, the reading solution contained 500 mM KI and
5 mM BODIPY. To discard artifacts, we verified by microscopy
that KI did not quench the fluorescence of LDs stained with
BODIPY. The fluorescence area/cell and the number of LDs did
not change significantly when 500 mM KI was added, suggesting
that iodide is excluded from LDs (Figure 3B and C). This
phenomenon allows researchers to measure the levels of lipid
Lipid Droplet Metabolism
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(Figure 1). Some fluorophores exhibit a red-shift of the
fluorescence spectra when in a non-polar environment, but the
absorbance and emission spectra of BODIPY were unaltered,
showing maximum absorbance at 485 nm and maximum emission
at 510 nm with excitation at 485 nm (Figure S3).
Figure 2. Quenchers of BODIPY fluorescence. A and B, Emission spectra (ex 485 nm) of a 5 mM aqueous solution of BODIPY in the presence of KI
(A), acrylamide (B) and tryptophane (C). The concentrations of KI and acrylamide were: none (#), 0.01 M (&), 0.1 M (m) and 1 M (.), Due to its
reduced solubility in the conditions tested, tryptophan was used at concentrations of 0 (#), 0.005 M (&), 0.01 M (m) and 0.02 M (.). RFU = relative
fluorescence unit.D–F, Stern-Volmer plots (indicate fluorescence quenching (F0/F) as a function of quencher concentration [39]) for BODIPY with
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To assess whether our method was able to detect small
fluctuations in LD levels, we quantified this parameter during
yeast growth as LDs are actively metabolized during growth
[23,40] (Figure 4A, B). Results obtained with the LFR assay
(Figure 4B) were similar to those obtained by quantifying the TAG
content (Figure 4C) or through microscopic analysis, from which
we calculated the total fluorescence area/cell. Furthermore it did
not reflect the number of LDs/cell that does not vary as much as
the size of LDs along the growth curve (Figure 4D, E). The results
were also in agreement with previous results obtained by
microscopic analysis [23] and biochemical quantification of
cellular TAG [40], which indicated that yeast cells consume LDs
when diluted in fresh medium. After six hours, LDs are re-
synthesized reaching highest levels at stationary phase [23,40].
This result demonstrates that our assay was able to detect small
physiological lipid stores fluctuations during yeast growth without
the need for time-consuming image analysis.
High-throughput experiment employing the LFR assay
We employed the LFR assay to study the involvement of protein
phosphatases in LD metabolism. In this high-throughput exper-
iment, we screened 96 null strains as well as the BY4741 WT
strain (14 independent WT clones). We subdivided the strains in
two groups. The first was a reference group, referred to as the lipid
synthesis group. This reference group included 31 null strains for
genes encoding LD-associated enzymes and/or enzymes involved
in the metabolism of sterols, the metabolism of triglycerides and
the biosynthesis of glycerolipids (Table 1) [41]. The second group,
referred to as the phosphatase group, was composed of 65 null
strains with all known non-essential protein phosphatases and non-
essential phosphatase regulatory subunits (Table 2), according to
the annotation in the Yeast Genome Database (www.yeastgen-
ome.org, October 2009). As LD content varies substantially during
growth (see Figure 4B) and not all strains have the same growth
rate, we decided to asses LD content in strains grown to stationary
phase, which was attained for all strains after 48 hours of seeding.
A histogram of the distribution of the lipid indexes for all strains
was analyzed and an index for cataloguing strains (as containing a
higher LD index (hlc) or a lower LD index (llc)) was elaborated
using an arbitrary cohort of 620% in relation to the LD index of
WT strains (Figure 5). When the mean LD index of the lipid
synthesis group was compared to that of the WT strain, no
significant difference was observed (means were 0.9539 and
0.9135, respectively p=0.276). The same trend was not observed
for the mean LD index of the protein phosphatase group, which
was significantly higher than the WT sample (1.023, p=0.0164)
and included an over-representation of hlc strains. Interestingly,
this result indicates that lipid accumulation is more likely provoked
by the random loss of protein phosphatase function as opposed to
the random loss of function among proteins involved in lipid
metabolism. After analyzing the groups as a whole, individual
strains were catalogued as having higher (hlc) or lower LD content
(llc) (Tables 1 and 2).
Most of the results obtained in the lipid synthesis group
corroborated results previously reported in the literature. Five
strains were identified as llc strains (hmg2, dga1, erg4, erg5, are2) and
Figure 3. The BODIPY fluorescence signal quenched by iodide
is recovered by the addition of cells to the medium. A. Increasing
amounts of formaldehyde-fixed cells were added (subsequent 5 ml
additions) to a 96-well plate containing 200 mlo f5mM BODIPY in the
presence of none (#), 0.1 M (m, yellow), 0.25 M (., orange), 0.50 M (¤,
green) or 1 M (N, red) KI. Fluorescence intensity (ex/em=485/510 nm)
and absorbance (600 nm) were recorded. A representative experiment
is shown. B. Cells grown in YPD to stationary phase were formaldehyde-
fixed, washed and resuspended to 10 DO 600 nm/ml. An aliquot of 5 ml
of cells was mixed with 5 ml BODIPY solution (10 mM) in the absence
(upper panel) or presence of 500 mM KI (lower panel). Stained cells
were analyzed by fluorescence microscopy (100x magnification). C.
Microscopy images were analyzed. The total fluorescence area/cell was
determined and expressed in pixels/cell (white bars). LDs per cell were
quantified using the same images (gray bars). Data are for at least 50
individual cells. No statistical difference was found between data
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among the llc strains we identified were dga1, which encodes an
enzyme responsible for the last step in TAG synthesis (acyl-CoA-
dependent pathway); hmg2, which encodes HMG-CoA reductase,
which catalyzes the rate-limiting step in ergosterol synthesis; and
are2, which esterifies sterols. Deletion of Dga1p and Are2p would
lead to diminished levels of TAG and sterol/steryl esters levels
[42], respectively. In the hlc group, we identified tgl3 which
encodes a TAG lipase. Deletion of this enzyme increases TAG
levels [12]. In the same group, we also identified slc1, which
encodes a 1-acylglycerol-3-phosphate acyltransferase involved in
phosphatidic acid biosynthesis. The exact role of this protein in
LD formation has not been demonstrated, but its deletion led to
higher TAG levels in cells [43]. Reinforcing our results, in a
previously published screening, dga1 and tgl3 were identified as
having diminished and increased number of LDs, respectively
[44]. Although we classified the erg4 and erg5 mutants as llc strains,
these strains have been reported to have more LDs than WT
strains when analyzed by fluorescent microscopy [44]. Microscop-
ic analysis confirmed that these strains have more LDs than WT
strains but show diminished total fluorescence area (Figure S4),
thus indicating a reduction in LD size. These results are interesting
because they suggest that fluctuations measured by LFR assay are
due to increased total fluorescence area. However the above
Figure 4. The liquid fluorescence recovery (LFR) assay can detect LD dynamics. A. Stationary yeast cells pre-grown for 48 hours, were
inoculated into fresh YPD medium and cellular growth was recorded by measuring absorbance at 600 nm over the course of 48 hours (n=36 S.D.).
B. Aliquots of cells were withdrawn during growth and fixed in formaldehyde. The LD index was determined (fluorescence/OD cells) using the LFR
assay (n=36 S.D.) C. The triacylglycerol content was measured during growth. D and E. LD content was determined by fluorescence microscopy. Cells
were grown for 0 (corresponding to 48 h pre-grown cells), 6 and 24 hours in YPD, incubated with BODIPY and photographed by fluorescence
microscopy. The total fluorescence area/cell (white bars) were determined and expressed in pixels/cell (white bars). LDs per cell were quantified using
the same images (gray bars). Data are for at least 50 individual cells. *p,0.05, ** p,0.01, ***p,0.001, in comparison to WT values.
doi:10.1371/journal.pone.0013692.g004
Lipid Droplet Metabolism
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to different levels of SE or TAG, or both. To test this we have
compared the fluorescence lipid droplet index and fluorescence
area/cell of are1are2 and dga1lro1 cells, lacking SE and TAG,
respectively (Figure S5). The mean fluorescence area/cell was
40% lower in are1are2 compared to WT while the LFR assay
showed an 8% reduction. The dga1lro1 presented a diffuse pattern
without distinguishable LDs when stained with BODIPY using the
same exposure times as WT being not valid to compare the
fluorescence area/cell, however with longer exposure times it was
possible to visualize a few LDs/cell. The LFR assay detected a
40% reduction in dga1lro1 LD index. These results show that the
LFR assay detects the total area/cell of lipid droplets composed of
mainly TAG or SE and that it is more sensitive than fluorescence
microscopy studies.
The Ser/Thr protein phosphatase Sit4p regulates Snf1
kinase phosphorylation in association with its regulatory
subunit Sap190p. Among the protein phosphatase group, three
strains were marked as llc (sit4, sap190 and reg1). Two of these
genes are related: SIT4 encodes the catalytic subunit of a type 2A-
like Ser-Thr phosphatase and SAP190 encodes one of its
regulatory subunits. REG1 codes for a regulatory subunit of Glc7
phosphatase, an essential type-1 protein phosphatase. On the
other hand, 10 strains were marked as hlc. Three of these were
type 2C protein phosphatases (ptc1, ptc4, ptc7); three were related to
type 1 protein phosphatases, a catalytic subunit (ppz2) and Glc7
regulatory subunits (gac1 and bni4). Pph21p is a type 2A protein
phosphatase and Sap185p is a regulatory subunit of Sit4p. Other
null strains marked as hlc were pps1 and msg5. These results call for
a new perspective on the topic at hand and indicate that an
intricate regulation of protein phosphorylation is involved in the
regulation of LD metabolism by protein phosphatases. Since
previous screens have missed sit4, sap190 and reg1 as having less
LDs we counted LDs and measured the fluorescent area/cell
(Figure 6). Results show that both parameters are significantly
lower compared to WT.
We further studied llc hits. Together with Tap42p, Sit4p is
known for its participation in the TOR pathway, which senses
nutrient availability and coordinates cell growth [45]. Sit4p was
first identified as a type2A-related phosphatase activated by
extracellular ceramide [46]. Sit4p is also regulated by four other
subunits thought to act as targeting subunits: Sap4p, Sap155p,
Sap185p and Sap190p. These proteins have different or
overlapping roles in the regulation of the cell cycle [47] and in
translation control [48]. Reg1p directs Glc7p to its targets,
participating in the regulation of several processes such as glucose
de-repression and glycogen synthesis [49,50]. Reg1p plays a role in
energetic metabolism by interacting with Snf1 kinase, a Ser/Thr
kinase homologue to mammalian AMPK responsible for main-
taining energy homeostasis. Upon depletion of glucose in the
medium, Snf1 is phosphorylated by upstream kinases (called Snf1-
activating kinases, SAKs) and becomes active [51]. Its dephos-
phorylation is promoted by Glc7p phosphatase and is dependent
on Reg1p, as the reg1 strain displays hyperphosphorylated Snf1p
[52]. However, this finding must be investigated further because
greater Reg1p-Snf1p interaction is observed in low-glucose
conditions when Snf1p is more active [53]. Snf1p kinase, in turn,
phosphorylates a key enzyme in FA biosynthesis, acetyl-CoA
carboxylase (Acc1), which inhibits the activity of Acc1. It has been
shown that deletion of SNF1 increases Acc1 activity as snf1 strain is
more resistant to soraphen A which is a potent inhibitor of acetyl-
CoA carboxylase – the more resistant a strain is, the greater is its
level of acetyl-CoA carboxylase activity [24,25,54].
We further investigated whether diminished LD content in sit4
strain was related to a lower rate of synthesis by following its
metabolism in a growing culture (Figure 7). Results show that sit4
strain was able to consume LDs after inoculating in fresh medium,
during the lag phase of growth, after which the rate of synthesis of
LDs was low compared to WT. This result points to a deficient
regulation of acetyl-CoA carboxylase activity. In fact, when the
phosphorylation state of Snf1p was analyzed during growth, we
observed that Snf1p is constitutively phosphorylated in sit4 strain,
while it is dephosphorylated in the WT strain during the early log
phase. Furthermore, phosphorylation of Snf1p increases through-
out culture growth and reaches a maximum during the late
Table 1. Lipid synthesis null strains screened by LFR assay.
NAME SYSTEMATIC
BIOLOGICAL
PROCESS MEAN S.D. P
HMG2
1 YLR450W STE synthesis 0.58 0.19 ,0.001
DGA1
1,* YOR245C TAG synthesis 0.59 0.16 ,0.001
ERG4
1,* YGL012W STE synthesis 0.70 0.18 0.003
ERG5
1,* YMR015C STE synthesis 0.71 0.28 0.007
ARE2
1 YNR019W SE synthesis 0.76 0.21 0.023
LRO1 YNR008W TAG synthesis 0.81 0.09 0.069
DPP1 YDR284C TAG synthesis 0.81 0.19 0.095
LPP1 YDR503C TAG synthesis 0.84 0.12 0.152
ERG2 YMR202W STE synthesis 0.84 0.06 0.164
GPT2 YKR067W TAG synthesis 0.85 0.06 0.178
CSG2 YBR036C Ceramide synthesis 0.85 0.26 0.233
TGL5 YOR081C TAG lipase 0.86 0.17 0.265
AYR1 YIL124W TAG synthesis 0.87 0.19 0.317
LAC1 YKL008C Ceramide synthesis 0.88 0.09 0.359
HMG1 YML075C STE synthesis 0.88 0.15 0.380
SUR2 YDR297W Ceramide synthesis 0.91 0.01 0.048
ARE1 YCR048W SE synthesis 0.91 0.10 0.626
IPT1 YDR072C Ceramide synthesis 0.93 0.09 0.782
LAG1 YHL003C Ceramide synthesis 0.94 0.01 0.577
TGL1 YKL140W SE hydrolase 0.99 0.03 0.189
YEH2 YLR020C SE hydrolase 1.00 0.08 0.540
ERG24 YNL280C STE synthesis 1.00 0.14 0.546
SCS7 YMR272C Ceramide synthesis 1.00 0.12 0.531
ERG6 YML008C STE synthesis 1.01 0.20 0.507
SCT1 YBL011W TAG synthesis 1.01 0.10 0.450
SUR1 YPL057C Ceramide synthesis 1.03 0.04 0.332
YEH1 YLL012W SE hydrolase 1.05 0.03 0.002
TGL4 YKR089C TAG lipase and SE
hydrolase
1.09 0.14 0.095
ERG3 YLR056W STE synthesis 1.10 0.27 0.107
SLC1
¥ YDL052C TAG synthesis 1.17 0.05 0.022
TGL3
¥,* YMR313C TAG lipase 1.37 0.17 ,0.001
7 out of 31 strains showed abnormal LP levels. Statistical analysis was performed
against WT values (mean fluorescence =0.95, S.D. =0.15, n=14). It was defined a
cutoff using an arbitrary 20% difference between the mutant and WT relative




were marked in bold. Gene descriptions based in SGD (www.yeastgenome.org).
*strains identified in a previously published screening for LP[25].
doi:10.1371/journal.pone.0013692.t001
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NAME SYSTEMATIC DESCRIPTION MEAN S.D. P
SIT4
1 YDL047W Type 2A-related protein phosphatase 0.63 0.09 ,0.001
REG1
1 YDR028C Regulatory subunit of type 1 protein phosphatase Glc7p 0.68 0.16 0.002
SAP190
1 YKR028W Regulatory subunit of Sit4 phosphatase 0.73 0.07 0.007
SIS2 YKR072C Regulatory subunit of type 1 protein phosphatase Ppz1 0.86 0.07 0.223
PIG2 YIL045W Subunit for the type-1 protein phosphatase Glc7p 0.89 0.12 0.450
LTP1 YPR073C Protein tyrosine phosphatase 0.90 0.12 0.518
RTS1 YOR014W Regulatory subunit of protein phosphatase 2A 0.91 0.07 0.598
YBR051W Dubious ORF, partially overlaps REG2 0.92 0.29 0.809
PTC6 YCR079W Type 2C protein phosphatase 0.92 0.10 0.636
GIP2 YER054C Subunit for the type-1 protein phosphatase Glc7p 0.92 0.11 0.646
YVH1 YIR026C Phosphotyrosine-specific protein phosphatase 0.92 0.13 0.653
CNA1 YLR433C Subunit of calcineurin, a type 2B protein phosphatase 0.92 0.10 0.661
PTC3 YBL056W Type 2C protein phosphatase 0.93 0.17 0.725
PTC5 YOR090C Type 2C protein phosphatase 0.93 0.08 0.722
GLC8 YMR311C Subunit for the type-1 protein phosphatase Glc7p 0.93 0.04 0.457
TIP41 YPR040W Interacts physically and genetically with Tap42p, regulates Sit4 0.93 0.09 0.781
SIW14 YNL032W Phosphotyrosine-specific protein phosphatase 0.94 0.10 0.821
CNB1 YKL190W Subunit of calcineurin, a type 2B protein phosphatase 0.94 0.08 0.897
RTS3 YGR161C Regulatory subunit of protein phosphatase 2A 0.95 0.10 0.930
PSR2 YLR019W Protein phosphatase involved in the general stress response 0.95 0.04 0.992
OCA2 YNL056W Putative protein tyrosine phosphatase 0.95 0.22 0.997
SDP1 YIL113W MAP kinase phosphatase 0.96 0.17 0.971
YNL010W Unknown function; similar to phosphoserine phosphatases 0.96 0.08 0.948
PTP1 YDL230W Phosphotyrosine-specific protein phosphatase 0.96 0.09 0.932
SIP5 YMR140W Unknown function; interacts with both the Reg1p/Glc7p 0.96 0.14 0.928
CMP2 YML057W Subunit of calcineurin, a type 2B protein phosphatase 0.97 0.12 0.866
YGR203W Phosphatase with sequence similarity to Cdc25p, Arr2p and Mih1p 0.97 0.14 0.814
PPH22 YDL188C Type 2A protein phosphatase 0.99 0.14 0.636
PPT1 YGR123C Ser/thr phosphatase with similarity to human phosphatase PP5 0.99 0.14 0.622
PPG1 YNR032W Putative serine/threonine protein phosphatase 1.00 0.07 0.596
PTC2 YER089C Type 2C protein phosphatase 1.01 0.15 0.522
RRD2 YPL152W Activator of the phosphotyrosyl phosphatase activity of PP2A 1.01 0.09 0.474
MIH1 YMR036C Protein tyrosine phosphatase 1.01 0.07 0.458
PIG1 YLR273C Subunit for the type-1 protein phosphatase Glc7p 1.01 0.15 0.467
GIP1 YBR045C Subunit for the type-1 protein phosphatase Glc7p 1.02 0.04 0.048
PHO13 YDL236W Alkaline phosphatase, also has protein phosphatase activity 1.02 0.09 0.382
SAP4 YGL229C Regulatory subunit of Sit4 phosphatase 1.03 0.16 0.376
NBP2 YDR162C Recruitment of phosphatase Ptc1p to the Pbs2p-Hog1p complex 1.04 0.07 0.264
PTP3 YER075C Phosphotyrosine-specific protein phosphatase 1.05 0.17 0.267
YER121W Putative protein of unknown function 1.05 0.07 0.249
VHS3 YOR054C Regulatory subunit of type 1 protein phosphatase Ppz1 1.05 0.15 0.255
NEM1 YHR004C Probable catalytic subunit of Nem1p-Spo7p phosphatase 1.05 0.10 0.246
PPZ1 YML016C Type 1 protein phosphatase 1.05 0.16 0.221
PSR1 YLL010C Protein phosphatase involved in the general stress response 1.05 0.11 0.210
PSY4 YBL046W Regulatory subunit of type 2A protein phosphatase Pph3 1.06 0.19 0.200
SAP155 YFR040W Regulatory subunit of Sit4 phosphatase 1.06 0.14 0.179
PPQ1 YPL179W Putative protein serine/threonine phosphatase 1.08 0.21 0.147
PPH3 YDR075W Type 2A protein phosphatase 1.09 0.04 0.091
PSY2 YNL201C Regulatory subunit of type 2A protein phosphatase Pph3 1.09 0.13 0.098
REG2 YBR050C Regulatory subunit of type 1 protein phosphatase Glc7p 1.09 0.05 0.086
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started to slow down (Figure 8). Interestingly Snf1p was also
constitutively phosphorylated in sap190 strain during all phases of
culture growth. To further confirm that Snf1p is in its active state
in sit4 strain (thus inhibiting acetyl-CoA carboxylase activity), we
screened the sensitivity of these null mutant strains to soraphen A
(Figure 9). Results revealed that sit4 strain is more sensitive to
soraphen A. reg1 strain has also been shown to be more sensitive to
soraphen A, and it has been shown that in this strain, Snf1p is in its
active state [55] and probably leads to an inhibition of acetyl-CoA
carboxylase. The results observed were consistent with the
classification of sit4 and reg1 as llc strains. As a control, we tested
the sensitivity of the snf1 strain. As expected, this resulted in
greater resistance to soraphen A due to the activation of acetyl-
CoA carboxylase activity [25,34]. Furthermore, we observed that
the snf1 strain presented an LD index that was higher than that of
the wild-type (Figure 9D).
The results oftesting the sensitivity ofSAPproteinsto soraphen A
show that sap190 strain leads to a probable inhibition of acetyl-CoA
carboxylase activity, which reinforces its classification as an llc
mutant. Interestingly, other Sap deletions led to an increase in
soraphen A resistance, which is not correlated to an increase in lipid
droplets. Such an effect can be explained because it is believed that
Saps compete among themselves for Sit4p association and, thus, the
deletion of one sap will increase the chances that Sit4 associates with
the remaining Saps [47]. These results suggest that the Sit4p-
Sap190p complex connects theTORpathway to the SNF1/AMPK
pathway to regulate lipid droplet metabolism (Figure 10).
Discussion
There is increasing interest in LD metabolism in the field of
biological science as more evidences connect its deregulation to
several pathological processes, such as the inflammatory response
[56], insulin resistance [57] and even neurodegenerative disorders
[58], in addition to the known role of LD in lipid storage.
However, there are still fundamental questions to be resolved
regarding the signaling pathways involved in LD regulation. The
methods employed in lipid studies have not facilitated great
advances; such investigations still rely on time-consuming and
expensive microscopic studies or on organic solvent extraction and
subsequent analysis. Working with such techniques requires well-
trained researchers because the steps involved can be tricky and
laborious. We propose an alternative, sensitive method for the
study of LD dynamics, which can be applied in high-throughput
experiments to yield reliable results.
BODIPY 493/503 is a BODIPY fluorophore derivative that,
due to its lipophilic nature, accumulates in LDs. It is often
employed in microscopic studies of these organelles as an
alternative to Nile red. In fact, Nile red acts more as a
hydrophobic probe because it only fluoresces in hydrophobic
environments in a manner that is proportional to the surrounding
hydrophobicity; it has been shown that Nile red stains both
membranes and LD [27,28]. On the other hand, BODIPY is more
specific than Nile red for LDs, as revealed by flow cytometry
experiments [26,29]. Furthermore, BODIPY seems to be less
sensitive to environmental conditions, such as pH and polarity
[59], which could be an advantage when comparing LD staining
in different mutant strains. Once optimal conditions were
determined, our assay was evaluated by following LD dynamics
during culture growth. In this experiment (Figure 4) the size (total
area/cell) and number of LDs was assayed by analyzing
microscope images of cells stained with BODIPY and TAG levels
were measured biochemically. Our fluorescence-based method
provided results consistent with the TAG content and with the size
of LDs. On the other hand, it did not correlate with the number of
LDs which do not vary substantially along the growth curve, when
compared to the size of LDs.
NAME SYSTEMATIC DESCRIPTION MEAN S.D. P
PTP2 YOR208W Phosphotyrosine-specific protein phosphatase 1.12 0.22 0.057
OCA1 YNL099C Putative protein tyrosine phosphatase 1.12 0.25 0.058
PAM1 YDR251W Essential protein of unknown function 1.13 0.15 0.028
PTC7
¥ YHR076W Type 2C protein phosphatase 1.14 0.22 0.028
PPS1
¥ YBR276C Protein phosphatase with specificity for Ser, Tthr and Tyr residues 1.15 0.10 0.017
SAP185
¥ YJL098W Regulatory subunit of Sit4 phosphatase 1.16 0.18 0.015
PPZ2
¥ YDR436W Type 1 protein phosphatase 1.18 0.12 0.007
MSG5
¥ YNL053W Dual-specificity protein phosphatase 1.18 0.21 0.009
PTC4
¥ YBR125C Type 2C protein phosphatase 1.20 0.19 0.004
SPO7 YAL009W Regulatory subunit of Nem1p-Spo7p phosphatase 1.22 0.30 0.172
PPH21
¥ YDL134C Type 2A protein phosphatase 1.23 0.17 0.002
GAC1
¥ YOR178C Subunit for the type-1 protein phosphatase Glc7p 1.25 0.14 0.001
BNI4
¥ YNL233W Subunit for the type-1 protein phosphatase Glc7p 1.26 0.11 0.002
PTC1
¥ YDL006W Type 2C protein phosphatase 1.28 0.26 ,0.001
TPD3 YAL016W Regulatory subunit of protein phosphatase 2A 1.52 0.39 0.127
13 out of 65 strains showed abnormal LP levels. Statistical analysis was performed against WT values (mean fluorescence =0.95, S.D. =0.15, from 14 WT samples). It was
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genes for lipid synthesis and LD dynamics have been knocked out
not only validated the entire screening but also reinforced the
reliability of our method. In a previous screening in which the
entire deletion library was analyzed microscopically to quantify
LDs [44], at least two of our hits (dga1 and tgl3) were identified as
inducing abnormal phenotypes. However, erg4 and erg5 strains,
which were identified as having increased LD number –
phenotypes we confirmed microscopically – were identified in
our screening as having lower fluorescence levels, which indicates
lower lipid content. A plausible explanation is that, although they
contain more LDs, these organelles are substantially smaller,
which could, in turn, result in reduced BODIPY capture and thus
less fluorescence. Interestingly, no relevant protein phosphatases
were identified in the previously mentioned screening. In here,
among 65 strains in which genes for protein phosphatases or
related subunits were knocked out, 10 presented higher lipid
droplet content while only 3 (reg1, sit4 and its regulatory subunit
sap190) presented lower lipid droplet content. This result suggests
that a loss of protein phosphatase function is more likely to result
Figure 5. Statistical analysis of a high-throughput experiment
employing the LFR assay. LDs were quantified by the LFR assay. The
frequency distribution of the relative LD index of strains from the lipid
synthesis group (A, n=31) and protein phosphatase group (B, n=65)
was calculated. Data were collected from four independent experi-
ments as described in the Materials and Methods section. The
D’Agostino & Pearson normality test was employed at P,0.05. The
lipid synthesis group was normally distributed (p=0.281), while the
protein phosphatase group failed to pass the normality test (p=0.016).
The arbitrary cohort (620% in relation to WT values) is indicated in the
graphs by a dashed line (llc, low lipid droplet content and hlc, high lipid
droplet content).
doi:10.1371/journal.pone.0013692.g005
Figure 6. LDs size and content in llc phosphatase mutants. The
total area/cell and the number of LDs were analyzed from microscopic
images of WT, sit4, sap190, reg1 grown in YPD medium for 48 hours, as
described. ** p,0.01, ***p,0.001, in comparison to WT values.
doi:10.1371/journal.pone.0013692.g006
Figure 7. LD dynamics is impaired in the sit4 strain. A. Stationary
yeast cells (WT, #, and sit4D,N) grown for 48 in YPD were inoculated
into fresh medium. Cellular growth was recorded by measuring
absorbance at 600 nm over the course of 25 hours. B. Lipid droplet
levels were determined by LFR assay during growth as described in
Figure 4. LD index was normalized by stationary WT value. The mean of
two independent experiments is shown.
doi:10.1371/journal.pone.0013692.g007
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analyzing the overall results our attention was drawn to the
involvement of three subunits of Glc7 phosphatase. gac1 and bni4
were identified as hlc while reg1 as llc. Glc7p phosphatase interacts
with different subunits each leading Glc7p to different substrates
regulating several cellular processes as cell cycle, glycogen, sugar
Figure 8. Snf1 kinase phosphorylation levels during growth. WT, sit4 and sap190 cells were grown in YPD at 30uC while shaking. Aliquots of
the culture were harvested at different times during growth (OD 600 nm of 1, 2, 4 or 5), and protein was extracted using the rapid NaOH extraction
method [31]. SDS-PAGE gels were loaded with 0.1 OD 600 nm cells per well. Snf1 phosphorylation was analyzed by western blot using anti-phospho
AMPKa antibody (P-SNF1, upper panel). As a control for loading, total Snf1 was revealed with anti-SNF1 antibody (lower panel). For autoradiography
the films were exposed for the minimum time necessary to detect the phosphorylation signal for WT grown to OD 1.0 which was used as reference.
The numbers below the figure represent the densitometry analysis of the P-SNF1/SNF1 ratio (n=3). Signals were linear unless marked by*.
doi:10.1371/journal.pone.0013692.g008
Figure 9. Soraphen A resistance profiles. Soraphen A resistance was determined by the microtiter assay and the spot assay. A and B. Serial
dilutions of soraphen A were used for the indicated strains (n=36 S.D.) IC50 were estimated (wt =0.19, snf1 =0.95, reg1 =0.11, sit4 =0.05, sap4
=0.36, sap155 =0.38, sap185 =0.38 and sap190=0.1 mg/ml). C. For the spot assay, serial dilutions (10
7,1 0
6 and 10
5 cells/mL, from left to right) of a
cellular suspension were seeded onto plates containing YPD solid medium in the presence of increasing concentrations of soraphen A and incubated




PLoS ONE | www.plosone.org 11 October 2010 | Volume 5 | Issue 10 | e13692and lipid metabolism [60,61]. Gac1p and Bni4p recruit Glc7p
phosphatase to glycogen synthase Gsy2p [62] or the bud neck
[63], respectively, and normally they may sequester some Glc7
phosphatase away from Snf1p. Their deletion might make more
Glc7p available for Reg1p-Snf1p, thus increasing Snf1p dephos-
phorylation/inactivation, thereby increasing Acc1p activity and
fatty acid synthesis. On the other hand interaction of Reg1p with
Glc7p is necessary to dephosphorylate Snf1p. Its deletion leads to
phosphorylation/activation of Snf1p, inhibiting the synthesis of
LDs.
These three genes, REG1, SIT4 and SAP190, have been
identified in a previous screen as necessary for normal growth
on oleic acid. The reason how the presence of Sap190p-Sit4p
prevents oleate inhibition is not known [64]. Kohlwein et al [17]
have shown that TAG synthesis plays an important role to buffer
excess oleic acid, as strains lacking the acyltransferases Lro1p,
Dga1p, Are1p, and Are2p are sensitive to this fatty acid. Together
with our results, these observations suggest that reg1, sit4 and
sap190 are necessary to induce synthesis of LDs in the presence of
oleate, thus preventing its toxicity.
We further studied the role of Sit4p participation in lipid
metabolism. The sit4 strain LD dynamics showed a lower rate of
LD synthesis after lag-phase, in comparison to WT (Figure 7).
Although we cannot discard defects in LD synthesis or the
degradation apparatus, the Sit4p deletion effect is likely due to the
diminished availability of construction blocks such as FA. In fact,
researchers believe that Sit4 phosphatase might dephosphorylate
acetyl-CoA carboxylase, a key enzyme in fatty acid metabolism.
However, experimental results have not been published [65–67].
Here, we showed that sit4 deletion increases sensitivity to soraphen
A, an acetyl-CoA carboxylase inhibitor. The same is observed for
the deletion of sap190, a regulatory subunit of SIT4. Moreover, it is
important to observe that sap185 deletion induced a phenotype
opposite to that elicited by sap190 deletion; the sap185 knockout
strain was detected as a high lipid content strain during screening.
Although SAPs compete for Sit4 binding [47] and have exhibited
opposing functions [68], so far, no antagonistic relationship
between Sap185p and Sap190p has been observed. More studies
will be necessary to answer whether the opposing LD phenotypes
resulting from these SAP genes deletions are related, indicating the
existence of a novel antagonistic pair.
To explore a possible connection between TOR and Snf1
signaling pathways (because Snf1 takes part in nitrogen signaling
and both are implicated in lifespan extension mechanisms), we
investigated Snf1 phosphorylation status in the sit4 strain.
Surprisingly, the deletion of sit4 (or its subunit sap190) leads to
increased constitutive Snf1 phosphorylation, being more active.
This finding would explain an increase in soraphen A sensitivity
due to a decrease in acetyl-CoA carboxylase activity. Although we
cannot discard the hypothesis that Sit4 directly dephosphorylates
acetyl-CoA carboxylase, we provide evidence that Sit4 participa-
tion in lipid metabolism occurs through the regulation of Snf1
phosphorylation status and links the TOR pathway to the AMP/
ATP-sensitive pathway, which is regulated by Snf1/AMPK.
Supporting Information
Figure S1 Liquid fluorescence recovery assay (LFR assay).
Schematic representation of the LFR assay, where cells are first
fixed in 3.7% formaldehyde, washed and then added to BODIPY-
quenched solution containing 5 mM BODIPY plus 500 mM KI.
Fluorescence is recovered and detected with a fluorimeter (ex/
em=485/510 nm).
Found at: doi:10.1371/journal.pone.0013692.s001 (1.46 MB TIF)
Figure S2 High-throughput screening of a knockout collection.
Individual strains are pre-grown to stationary phase at 30uC and
fixed in formaldehyde (3.7%). Cells are washed and added to a 96-
well black-wall/clear-bottom plate. Fluorescence (ex/em=485/
510 nm) and absorbance (600 nm) are recorded. Three more
subsequent readings were performed after the addition of cells to
the wells in order to determine the LD index.
Found at: doi:10.1371/journal.pone.0013692.s002 (0.46 MB TIF)
Figure S3 Fluorescence properties of BODIPY are not altered in
the presence of cells. An aqueous solution of BODIPY (5 mM) was
incubated in the presence of the indicated of none (O), 0.025 OD
(square), 0.05 OD (D) and 0.1 OD (=) of cells and the absorption
spectra (upper panel) and emission (excitation at 485 nm) (lower
panel) of BODIPY were recorded. Results are in agreement with
information provided by the manufacturer (BODIPY Lipid Probes
manual, available online at www.invitrogen.com), which states
that BODIPY-derivative fluorescence parameters are insensitive to
environmental conditions and not quenched by water.
Found at: doi:10.1371/journal.pone.0013692.s003 (0.62 MB TIF)
Figure S4 LD content in erg4 and erg5 strains was determined by
fluorescence microscopy. Cells were grown to stationary phase and
incubated with BODIPY. The total fluorescence area/cell was
determined and expressed in pixels/cell (white bars). LDs per cell
were quantified using the same images (gray bars). Data provided
are for at least 100 individual cells. LD index is indicated below
the graph for each strain. *p,0.05, ** p,0.01, ***p,0.001, in
comparison to WT values.
Found at: doi:10.1371/journal.pone.0013692.s004 (1.59 MB TIF)
Figure S5 LD index correlates with either TAG or SE content.
WT, are1D are2D and dga1D lro1D strains were grown to stationary
phase and incubated with BODIPY. Images were captured for
Figure 10. Sit4p orchestrates lipid metabolism in response to
nutrients. Snf1 kinase, a central regulator of energetic homeostasis,
when phosphorylated and active, inhibits acetyl CoA carboxylase
activity impairing fatty acids synthesis diminishing LD levels. It is
dephosphorylated by Reg1/Glc7 phosphatase as glucose levels in the
medium increase [50]. Our results suggest that the Sap190-Sit4 pair also
participates in Snf1 dephosphorylation and links the TOR pathway to
the AMP/ATP-sensitive pathway, mediated by Snf1.
doi:10.1371/journal.pone.0013692.g010
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(last panel). At the bottom of the figure the LD index (LFR assay)
(n=3) and size (fluorescence area/cell LDs, microscopy images
n=100 cells) for each strain are shown. ** p,0.01, ***p,0.001,
in comparison to WT values.
Found at: doi:10.1371/journal.pone.0013692.s005 (2.78 MB TIF)
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